Electronic cigarette prevalence and patterns of use in adults with a history of cardiovascular disease in the United States

Journal of the American Heart Association

Volumn 7, Issue 9, 2018, Pages

  Stokes, Andrew ^a   Collins, Jason M ^a   Berry, Kaitlyn M ^a   Reynolds, Lindsay M ^b   Fetterman, Jessica L ^c   Rodriguez, Carlos J ^b   Siegel, Michael B ^a   Benjamin, Emelia J ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; e cigarettes; Epidemiology; Smoking; Smoking cessation

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ELECTRONIC CIGARETTE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; SECONDARY ANALYSIS; SMOKING; SMOKING CESSATION; UNITED STATES; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; ADVERSE EVENT; CROSS-SECTIONAL STUDY; HEALTH SURVEY; PREVENTION AND CONTROL; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TIME FACTOR; VAPING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKERS; SMOKING CESSATION; TIME FACTORS; TOBACCO SMOKING; UNITED STATES; VAPING; YOUNG ADULT;

EID: 85046418876     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.117.007602     Document Type: Article

References (44)

1. US Burden of Disease Collaborators. The state of US health, 1990 to 2010: burden of diseases, injuries and risk factors. JAMA. 2013;310:591-608.
2. Kochanek KD, Murphy SL, Xu J. Deaths: final data for 2011. Natl Vital Stat Rep. 2015;63;1-120.
3. Benjamin E, Blaha M, Chiuve S, Cushman M, Das S, Deo R, de Ferranti S, Floyd J, Fornage M, Gillespie C, Isasi C, Jimenez M, Jordan L, Judd S, Lackland D, Lichtman J, Lisabeth L, Liu S, Longenecker C, Mackey R, Matsushita K, Mozaffarian D, Mussolino M, Nasir K, Neumar R, Palaniappan L, Pandey D, Thiagarajan R, Reeves M, Ritchey M, Rodriguez C, Roth G, Rosamond W, Sasson C, Towfighi A, Tsao C, Turner M, Virani S, Voeks J, Willey J, Wilkins J, Wu J, Alger H, Wong S, Muntner P. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 2013;127:e6-e245.
4. United States Department of Health and Human Services. The health consequences of smoking-50 years of progress a report of the surgeon general. A Rep Surg Gen. 2014. Available at: https://globalhealth.usc.edu/ 2014/01/17/the-health-consequences-of-smoking-50-years-of-progress-a-re port-of-the-surgeon-general/. Accessed March 14, 2018.
5. U.S. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. 2010. Available at: https://www.ncbi.nlm.nih.gov/books/NBK53017/. Accessed March 14, 2018.
6. Teo KK, Ounpuu S, Hawken S, Pandey M, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368:647-658.
7. Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF, Jones DW, Lloyd-Jones DM, Minissian M, Mosca L, Peterson ED, Sacco RL, Spertus J, Stein JH, Taubert KA. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:2458-2473.
8. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290:86-97.
9. Shah AM, Pfeffer MA, Hartley LH, Moye LA, Gersh BJ, Rutherford JD, Lamas GA, Rouleau JL, Braunwald E, Solomon SD. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction. Am J Cardiol. 2010;106:911-916.
10. Gerber Y, Rosen LJ, Goldbourt U, Benyamini Y, Drory Y. Smoking status and long-term survival after first acute myocardial infarction: a population-based cohort study. J Am Coll Cardiol. 2009;54:2382-2387.
11. Rea TD, Heckbert SR, Kaplan RC, Smith NL, Lemaitre RN, Psaty BM. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med. 2002;137:494-500.
12. Quiñones AR, Nagel CL, Newsom JT, Huguet N, Sheridan P, Thielke SM. Racial and ethnic differences in smoking changes after chronic disease diagnosis among middle-aged and older adults in the United States. BMC Geriatr. 2017. Available at: https://bmcgeriatr.biomedcentral.com/articles/10.1186/s128 77-017-0438-z. Accessed March 14, 2018.
13. Centers for Disease Control and Prevention. Trends in Current Cigarette Smoking Among High School Students and Adults, United States, 1965-2014. Smoking & Tobacco Use.
14. Glasser AM, Collins L, Pearson JL, Abudayyeh H, Niaura RS, Abrams DB, Villanti AC. Overview of electronic nicotine delivery systems: a systematic review. Am J Prev Med. 2017;52:e33-e66.
15. Regan AK, Promoff G, Dube SR, Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the "e-cigarette" in the USA. Tob Control. 2013;22:19-23.
16. McMillen RC, Gottlieb MA, Whitmore Shaefer RM, Winickoff JP, Klein JD. Trends in electronic cigarette use among U.S. adults: use is increasing in both smokers and nonsmokers. Nicotine Tob Res. 2015;17:1195-1202.
17. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382:1629-1637.
18. Weaver SR, Majeed BA, Pechacek TF, Nyman AL, Gregory KR, Eriksen MP. Use of electronic nicotine delivery systems and other tobacco products among USA adults, 2014: results from a national survey. Int J Public Health. 2016;61:177-188.
19. Orellana-Barrios MA, Payne D, Medrano-Juarez RM, Yang S, Nugent K. Electronic cigarettes for smoking cessation. Am J Med Sci. 2016;352:420-426.
20. Hajek P. Electronic cigarettes for smoking cessation. Lancet. 2013;382:1614- 1616.
21. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Policy. 2011;32:16-31.
22. Delnevo CD, Giovenco DP, Steinberg MB, Villanti AC, Pearson JL, Niaura RS, Abrams DB. Patterns of electronic cigarette use among adults in the United States. Nicotine Tob Res. 2015;18:715-719.
23. Wilson FA, Wang Y. Recent findings on the prevalence of e-cigarette use among adults in the U.S. Am J Prev Med. 2017;52:385-390.
24. IPUMS-USA. IPUMS health surveys. Available at: https://nhis.ipums.org/ nhis/. Accessed February 20, 2018.
25. Parsons VL, Moriarity C, Jonas K, Moore TF, Davis KE, Tompkins L. Design and estimation for the national health interview, 2006-2015. National Center for Health Statistics. Vital Heal Stat 2. 2014;2:1-53.
26. Blewett LA, Rivera Drew JA, Griffin R, King ML, Williams K. IPUMS Health Surveys: National Health Interview Survey, Version 6.2. Minneapolis: University of Minnesota; 2016.
27. Syamlal G, Jamal A, King BA, Mazurek JM. Electronic cigarette use among working adults-United States, 2014. Morb Mortal Wkly Rep. 2016;65:557- 561.
28. Schoenborn C, Gindi R. Electronic cigarette use among adults: United States, 2014. NCHS Data Brief. 2015;217:1-7.
29. Coleman BN, Rostron B, Johnson SE, Ambrose BK, Pearson J, Stanton CA, Wang B, Delnevo C, Bansal-travers M, Kimmel HL, Goniewicz ML, Niaura R, Abrams D, Conway KP, Borek N, Compton WM, Hyland A. Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014. Tob Control. 2017;26:e117-e126.
30. Zhu S-H, Zhuang Y-L, Wong S, Cummins SE, Tedeschi GJ. E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ. 2017;358:1-8.
31. Qasim H, Karim ZA, Rivera JO, Khasawneh FT, Alshbool FZ. Impact of electronic cigarettes on the cardiovascular system. J Am Heart Assoc. 2017;6: e006353. DOI: 10.1161/JAHA.117.006353.
32. Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead L, Hajek P. Electronic cigarettes for smoking cessation (Review). Cochrane Database Syst Rev. 2016. doi:10.1002/14651858.CD010216.pub3.
33. Pisinger C, Dossing M. A systematic review of health effects of electronic cigarettes. Prev Med. 2014;69:248-260.
34. Farsalinos KE, Tsiapras D, Kyrzopoulos S, Savvopoulou M, Voudris V. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord. 2014;14:78.
35. Yan XS, D'Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul Toxicol Pharmacol. 2015;71:24-34.
36. Antoniewicz L, Bosson JA, Kuhl J, Abdel-Halim SM, Kiessling A, Mobarrez F, Lundback M. Electronic cigarettes increase endothelial progenitor cells in the blood of healthy volunteers. Atherosclerosis. 2016;255:179-185.
37. Carnevale R, Sciarretta S, Violi F, Nocella C, Loffredo L, Perri L, Peruzzi M, Marullo AGM, De Falco E, Chimenti I, Valenti V, Biondi-Zoccai G, Frati G. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest. 2016;150:606-612.
38. Olfert M. Acute and chronic effects of e-cigarette vapor exposure on vascular function: new friend or old foe? Cardiovascular Aging: New Frontiers and Old Friends. 2017. Available at: http://www.the-aps.org/mm/Conferences/APSConferences/ 2017-Conferences/CV-Aging/Schedule/Program-of-Symposia. PDF. Accessed March 14, 2018.
39. Moheimani R, Bhetraratana M, Yin F, Peters K, Gorbein J, Araujo J, Middlekauff H. Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: implications for cardiovascular risk. JAMA Cardiol. 2017;2:278-284.
40. Lerner CA, Sundar IK, Watson RM, Elder A, Jones R, Done D, Kurtzman R, Ossip DJ, Robinson R, McIntosh S, Rahman I. Environmental health hazards of e-cigarettes and their components: oxidants and copper in e-cigarette aerosols. Environ Pollut. 2015;198:100-107.
41. Bhatnagar A, Whitsel LP, Ribisl KM, Bullen C, Chaloupka F, Piano MR, Robertson RM, McAuley T, Goff D, Benowitz N. Electronic cigarettes: a policy statement from the American Heart Association. Circulation. 2014;130:1418- 1436.
42. Bhatnagar A. Cardiovascular perspective of the promises and perils of ecigarettes. Circ Res. 2016;118:1872-1875.
43. Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol. 2017;14:447-456.
44. Gornall J. Why e-cigarettes are dividing the public health community. Br Med J. 2015;350:h3317.